A cost benefit analysis of BCG vaccination as a control measure against tuberculosis as compared to treatment of infectious cases

Naganna, K. (1975) A cost benefit analysis of BCG vaccination as a control measure against tuberculosis as compared to treatment of infectious cases. Indian Journal of T uberculosis, 22 (1). pp. 5-8.

Full text available as:

PDF - Requires Adobe Acrobat Reader or other PDF viewer.
130 Kb

Abstract

BCG vaccination as a measure of control of Tuberculosis has been advocated particularly for developing countries. A controlled study conducted in South India suggests that BCG vaccination would have an impact of only about 8 percent on the total tuberculosis expected during 20-21 years.

EPrint Type:Article
Uncontrolled Keywords:BCG Vaccination, Tuberculosis, Control Measure, Infectious Cases, Tuberculosis Control Programme, South India, Cost Benefit Analysis, Cost of Treatment
Subjects:Bacterial Infections and Mycoses > Bacterial Infections > Gram-Positive Bacterial Infections > Actinomycetales Infections > Mycobacterium Infections
Health Care Economics and Organizations > Health Planning > National Health Programs
Therapeutics > Biological Therapy > Immunotherapy > Immunization > Immunotherapy, Active > Vaccination
Respiratory Tract Diseases > Respiratory Tract Infections > Tuberculosis, Pulmonary
Respiratory Tract Diseases > Lung Diseases > Tuberculosis, Pulmonary
-Journal Repositories > Indian Journal of Tuberculosis
Social Sciences > Economics
Health Care Economics and Organizations > Economics
Immunologic and Biological Factors > Biological Products > Vaccines > Bacterial Vaccines > Tuberculosis Vaccines > BCG Vaccine
ID Code:1536
Deposited By:Mrs Naina Pandita
Deposited On:23 June 2006

Archive Staff Only: edit this record